EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 28 May 2025

EFPIA highlights three priorities to boost Europe's competitiveness at the Euractiv Conference

How can we boost Europe’s competitiveness?

Ensure all legislations are coherent and don't have unintended consequences on pharmaceuticals
Strengthen Europe’s intellectual property provisions
Reward innovation: investing in health is not a cost, but an investment

Hear more from Roberta Savli, EFPIA Executive Director of Public Affairs, at the 2025 Euractiv Health Policy Conference.

Vaccination against respiratory infections can reduce the risk of complications associated with CVD

Respiratory infections can increase the risk of CVDs among all people. Studies show that for CVD patients diagnosed with flu, the risk of experiencing a heart attack increases 6-fold. Additionally, patients have a 3 times increased risk of experiencing a stroke after a systemic respiratory infection.

Learn how vaccination can be a strategic tool for protecting cardiovascular health across Europe.

Events

IHI Call Days - call 11
23 June 2025 (Virtual event)

The IHI Call Days for IHI call 11 will take place from 23 to 30 June 2025 online and will include sessions on the individual... Read more

EU-X-CT Public Stakeholder Conference: Final recommendations launch
24 June 2025 (Brussels, hybrid event)

Borders should no longer be barriers in clinical trials. Read more

FACILITATE 2025 Webinar - Return of individual participant data in clinical trials
25 June 2025 (Virtual event)

Organised by Active Citizenship Network, this webinar will bring together key voices from across sectors to explore... Read more

Biotech Business Mission to Japan 2025 - Call for applications
06 October 2025 (Osaka & Yokohama, Japan)

Join the biotech business mission in Japan from 6-10 October 2025, organised by the EU-Japan Centre for Industrial Cooperation.... Read more

What we are reading

Getting medicine to children with cancer faster with ITCC-P4
On 27 May 2025 (IHI)

Children with cancer can’t wait for new drugs. ITCC-P4 is accelerating how quickly they come to the market.

IRDiRC - Funding Models to support the spectrum of rare disease research and development
On 20 May 2025 (IRDiRC)

Discover the IRDiRC Funding Models for Rare Diseases Research Toolbox. Designed to support patient advocacy organizations... Read more

The European Health Data Space
On 17 May 2025 (The Lancet)

New health data regulations promise to empower patients and help research, but can they overcome difficulties in... Read more

Prioritising Alzheimer’s disease policy in Europe: Insights from oncology
On 15 May 2025 (CRA)

The burden of Alzheimer’s disease (AD) for health and care systems in Europe is increasing.

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu